On-label and off-label drug use in the treatment of endometriosis

Alexander M Quaas, Alexander Quaas, Elizabeth A Weedin, Karl R Hansen
Fertility and sterility · 2015 · vol. 103(3) , pp. 612–625 · doi:10.1016/j.fertnstert.2015.01.006 · PMID:25637479 · W2013161515
review OA: bronze CC0 ⤵ 32 in-corpus citations
🔓 Open OA copy View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This paper reviews the on-label and off-label prescription drug treatments currently used for endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Drug Labeling Drug Prescriptions Endometriosis Off-Label Use Contraceptives, Oral, Hormonal Contraceptives, Oral, Hormonal Endometriosis Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Humans Ovulation Inhibition Ovulation Inhibition Progestins Progestins United States United States Food and Drug Administration

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (100)

Cited by (32)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:18:04.362919+00:00
License: CC0 · commercial use OK